close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar968172Point72
Implied share price

Buy Undervalued by 1269634.7%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
SNY
Sanofi SA (ADR)
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
306760.63 23.69 392789.88 6.26 22.81 17.08
All amounts in millions
from last financial year
         
Implied Share Price $968172.72 $48789.09 $2860585.17 $971172.53 $1648521.75
Market Cap 18,291 1,229,412 138,212 106,542 100,042
Net Debt -371 20 8,094 4,504 -3,369
Enterprise Value (EV) 18,961 1,229,432 77,815 111,046 96,673
Revenue 4,048 44 35,957 11,201 13,418
EBITDA 800 3 12,422 4,868 5,661
Percent 19.8 % 7.1 % 34.5 % 43.5 % 42.2 %
EBIT 332 1 7,825 4,524 5,069
Percent 8.2 % 3.6 % 21.8 % 40.4 % 37.8 %
Balance Sheet          
Total Assets 10,913 58 100,407 22,496 21,787
Total Liabilities 3,326 56 43,069 11,127 6,116
Shareholders Equity 7,586 2 57,338 11,369 15,671.0

Comments

No comments yet. Login to comment.